Influenza Therapeutics in Clinical Practice—Challenges and Recent Advances-Reference-Cited by-同舟云学术

Influenza Therapeutics in Clinical Practice—Challenges and Recent Advances

Published:2020-02-10 Issue:4 Volume:11 Page:a038463
ISSN:2157-1422
Container-title:Cold Spring Harbor Perspectives in Medicine
language:en
Short-container-title:Cold Spring Harb Perspect Med

Author:

Beigel John H.,Hayden Frederick G.

Publisher

Cold Spring Harbor Laboratory

Subject

General Biochemistry, Genetics and Molecular Biology

Reference135 articles.

1. A Phase 2a Study to Evaluate the Safety of MEDI8852 in Outpatient Adults with Acute, Uncomplicated Influenza A

2. Baker J . 2019. Single-dose baloxavir is well tolerated and effective for treatment of influenza in otherwise healthy children aged 1 to <12 years: a randomized, double-blinded, active-controlled study (Ministone-2). Options X for the Control of Influenza, Abstract 11756. Singapore, Aug 28–Sept 1.

3. T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro

4. The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome

5. Animal models for the study of influenza pathogenesis and therapy

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PEG-SeNPs as therapeutic agents inhibiting apoptosis and inflammation of cells infected with H1N1 influenza A virus;Scientific Reports;2024-09-12

2. One-pot synthesis, characterization and antiviral properties of new benzenesulfonamide-based spirothiazolidinones;Molecular Diversity;2024-06-27

3. Outlining recent updates on influenza therapeutics and vaccines: A comprehensive review;Vaccine: X;2024-03

4. Gripe estacional infantil;EMC - Pediatría;2024-03

5. A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration;Scientific Reports;2024-02-15